Rapid Detection of Urinary Tract Pathogens
HealthTrackRx (HTRx) is the premier specialty diagnostic laboratory dedicated to the detection of infectious diseases.
With a decades-long track record of industry-leading technological advancement, our assays deliver accurate, actionable data with best-in-class turnaround time.
99% of samples received by our lab are reported out within 24-36 hours of receipt.
Eliminate the Guesswork in Diagnosis and Treatment
Our UTI pathogen assay utilizes the latest in quantitative RT-PCR technology to rapidly and reliably analyze your patient’s sample.
We rapidly detect and differentiate 99% of the most relevant bacterial, viral, and fungal targets, eliminating the need for costly, inaccurate, and time-consuming follow up testing.
Our molecular technique provides a more definitive diagnosis than POC antigen assays*
Our UTI Diagnostics:
- Reduce false negatives
- Detect polymicrobial infections
- Are unaffected by concurrent antibiotic use
- Include one of the most extensive antibiotic resistance gene menus
- Reduce unnecessary drug exposure and adverse events
- Report within 24-36 hours of sample receipt
Prescribe with Confidence
As the leader in testing sensitivity and specificity, our reports include a custom-designed accurate and detailed antibiogram.
- Support antibiotic stewardship by reducing over-utilization of broad-spectrum anti-infectives
- Decrease the need for empiric therapy
- Reduce unnecessary drug exposure, adverse events, cost of repeat testing, and multiple treatment attempts
The New 99%
Over 99% of results are reported within 24-36 hours of sample receipt
Over 99% sensitivity to reduce false negatives
Over 99% specificity to reduce false positives
Over 99% of the most common pathogens detected
100% trackable samples and results
UTI Pathogens Profile
Candida albicans, glabrata, parapsilosis, tropicalis
Enterobacter aerogenes, cloacae
Enterococcus faecalis, faecium
Klebsiella pneumoniae, oxytoca
Mycoplasma genitalium, hominus
Proteus mirabilis, vulgaris
Staphylococcus (coagulase negative: epidermidis, haemolyticus, lugdunensis, saprophyticus)
Streptococcus agalactiae (Group B strep (GBS))
Streptococcus pyogenes (Group A strep)
Ureaplasma urealyticum, parvum
VanA, VanB (Vancomycin resistance)
ermB, C; mefA (Macrolide Lincosamide Streptogramin)
SHV, KPC Groups (Class A beta lactamase)
dfr (A1, A5), sul (1, 2) probes (Trimethoprim/Sulfamethoxazole resistance)
mecA (Methicillin gene)
qnrA1, qnrA2, qnrB2 (Fluoroquinolone genes)
tet B, tet M (Tetracycline genes)
IMP, NDM, VIM Groups (Class B metallo beta lactamase)
ACT, MIR, FOX, ACC Groups (AmpC beta lactamase)
OXA-48,-51 (Class D oxacillinase)
CTX-M1 (15), M2 (2), M9 (9), M8/25 Groups (Class A beta lactamase)
*Van der Zee A, Roorda L, Bosman G, Ossewaarde JM (2016) Molecular Diagnosis of Urinary Tract Infections by Semi-Quantitative Detection of Uropathogens in a Routine Clinical Hospital Setting. PLoS ONE 11(3): e0150755. Doi:10.1371/journal.pone.0150755